Richelle P. Parham, a director of Labcorp Holdings Inc., filed a Form 144 notice on October 30, 2026, proposing to sell 1,078 shares of common stock on the New York Stock Exchange through Fidelity Brokerage Services LLC.

Key Highlights

  • Seller: Richelle P. Parham, identified in the filing as a Director of Labcorp Holdings Inc.
  • Shares proposed for sale: 1,078 shares of common stock, with an aggregate market value of $389,395.16 according to the filing.
  • Approximate date of sale: October 30, 2026, to be executed on the NYSE.
  • Original acquisition: The shares were acquired on February 9, 2017, via restricted stock vesting from the issuer, with compensation listed as the nature of payment.
  • Shares outstanding: The filing lists 81,100,000 shares of common stock outstanding.
  • Prior sales activity: The filing reports nothing to report for securities sold during the past three months.
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.

Labcorp Director Proposes Rule 144 Sale of Restricted Stock Shares

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Richelle P. Parham, a director of Labcorp Holdings Inc. (NYSE:LH), is proposing to sell 1,078 shares of the company's common stock. The filing states the aggregate market value of the proposed sale is $389,395.16. The notice was dated October 30, 2026, and the approximate date of sale is also listed as October 30, 2026.

The filing discloses that the 1,078 shares were originally acquired on February 9, 2017, through a restricted stock vesting transaction from the issuer. The nature of payment at the time of acquisition is listed as compensation. The proposed sale is to be executed through Fidelity Brokerage Services LLC on the New York Stock Exchange, with Wade Moss signing as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Richelle P. Parham.

The filing reports no securities of Labcorp Holdings Inc. were sold by Parham during the three months preceding this notice. The filing lists the total number of shares of common stock outstanding as 81,100,000. The filing also includes the standard representation that the seller "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed," as stated in the notice.

What Was Disclosed

Richelle P. Parham, a director at Labcorp Holdings Inc., filed a Form 144 notice on October 30, 2026, proposing the sale of 1,078 restricted shares originally vested in February 2017, with an aggregate market value of $389,395.16, through Fidelity Brokerage Services LLC on the NYSE.